| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 18:40:57 UTC |
|---|
| Update Date | 2021-09-26 23:14:09 UTC |
|---|
| HMDB ID | HMDB0257652 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide |
|---|
| Description | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review very few articles have been published on (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-2-(benzenesulfonamido)-n-[(1s)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)NC(C(C)C)C(O)C1=C(C1=O)C1=CC=CC=C1 InChI=1S/C26H32N2O5S/c1-16(2)15-20(28-34(32,33)19-13-9-6-10-14-19)26(31)27-23(17(3)4)25(30)22-21(24(22)29)18-11-7-5-8-12-18/h5-14,16-17,20,23,25,28,30H,15H2,1-4H3,(H,27,31) |
|---|
| Synonyms | | Value | Source |
|---|
| (2S)-2-(Benzenesulphonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide | Generator | | 2-Benzenesulfonamido-N-[1-hydroxy-3-methyl-1-(3-oxo-2-phenylcycloprop-1-en-1-yl)butan-2-yl]-4-methylpentanimidate | HMDB | | 2-Benzenesulphonamido-N-[1-hydroxy-3-methyl-1-(3-oxo-2-phenylcycloprop-1-en-1-yl)butan-2-yl]-4-methylpentanimidate | HMDB | | 2-Benzenesulphonamido-N-[1-hydroxy-3-methyl-1-(3-oxo-2-phenylcycloprop-1-en-1-yl)butan-2-yl]-4-methylpentanimidic acid | HMDB |
|
|---|
| Chemical Formula | C26H32N2O5S |
|---|
| Average Molecular Weight | 484.61 |
|---|
| Monoisotopic Molecular Weight | 484.203193312 |
|---|
| IUPAC Name | 2-benzenesulfonamido-N-[1-hydroxy-3-methyl-1-(3-oxo-2-phenylcycloprop-1-en-1-yl)butan-2-yl]-4-methylpentanamide |
|---|
| Traditional Name | 2-benzenesulfonamido-N-[1-hydroxy-3-methyl-1-(3-oxo-2-phenylcycloprop-1-en-1-yl)butan-2-yl]-4-methylpentanamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)NC(C(C)C)C(O)C1=C(C1=O)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C26H32N2O5S/c1-16(2)15-20(28-34(32,33)19-13-9-6-10-14-19)26(31)27-23(17(3)4)25(30)22-21(24(22)29)18-11-7-5-8-12-18/h5-14,16-17,20,23,25,28,30H,15H2,1-4H3,(H,27,31) |
|---|
| InChI Key | AHGUSCIGPLCZRU-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Leucine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Leucine or derivatives
- Alpha-amino acid amide
- Benzenesulfonamide
- Benzenesulfonyl group
- Fatty acyl
- Benzenoid
- Organosulfonic acid amide
- N-acyl-amine
- Fatty amide
- Monocyclic benzene moiety
- Aminosulfonyl compound
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Cyclic ketone
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic alcohol
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Alcohol
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 213.798 | 30932474 | | DeepCCS | [M-H]- | 211.403 | 30932474 | | DeepCCS | [M-2H]- | 244.285 | 30932474 | | DeepCCS | [M+Na]+ | 219.711 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.91 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.9623 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.99 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2694.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 204.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 201.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 164.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 160.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 565.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 547.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 77.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1142.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 556.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1494.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 329.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 420.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 154.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 148.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3451.4 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3610.0 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4593.6 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 3448.1 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 3536.4 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 4433.1 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3441.1 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3646.2 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4669.7 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3477.9 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3740.1 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C)N([Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4360.9 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3860.8 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4060.3 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4610.0 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 3879.2 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 3975.0 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #2 | CC(C)CC(NS(=O)(=O)C1=CC=CC=C1)C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 4497.8 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3904.1 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4083.5 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,2TBDMS,isomer #3 | CC(C)CC(C(=O)N(C(C(C)C)C(O)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4662.6 | Standard polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4084.2 | Semi standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4436.8 | Standard non polar | 33892256 | | (2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C(C(C)C)C(O[Si](C)(C)C(C)(C)C)C1=C(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4414.4 | Standard polar | 33892256 |
|
|---|